BIOTRICITY INC (BTCY) earnings
BTCY earnings moved a median of +0.57% by the close. Quarterly and annual BTCY reports and results, each read against the price at its own news timestamp. Back to the BTCY overview →
22 measured BTCY earnings events.
Where these BTCY earnings landedvs 22 measured BTCY earnings reactions
| Middle 50% of BTCY earnings reactions | -4.38% to +6.82% |
|---|---|
| Median reaction (to close) | +0.57% |
| Measured reactions | 22 |
Point-in-time · zero look-ahead
Half of the 22 BTCY earnings events with a measured close landed between -4.38% and +6.82%; 50% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q BIOTRICITY INC. For: Jun 30 | SEC filing · Form 10-Q | +5.27% | +5.27% | |
| Form NT 10-Q BIOTRICITY INC. For: Jun 30 | SEC filing · Form NT | — | +0.00% | |
| Form 10-K BIOTRICITY INC. For: Mar 31 | SEC filing · Form 10-K | +0.00% | +36.05% | |
| Form NT 10-K BIOTRICITY INC. For: Mar 31 | SEC filing · Form NT | +0.00% | -22.90% | |
| Form 10-Q BIOTRICITY INC. For: Dec 31 | SEC filing · Form 10-Q | +0.00% | -4.00% | |
| Form 10-Q BIOTRICITY INC. For: Sep 30 | SEC filing · Form 10-Q | — | +1.13% | |
| Biotricity Reinforces Growth Trajectory, Kicking Off Fiscal 2026 with Strong First Quarter Results Featuring Revenue Growth, Positive EBITDA and Improved Margins | Press release | +0.50% | -9.55% | |
| Form 10-Q BIOTRICITY INC. For: Jun 30 | SEC filing · Form 10-Q | +0.50% | -9.55% | |
| Form 10-K/A BIOTRICITY INC. For: Mar 31 | SEC filing · Form 10-K | +0.00% | +6.24% | |
| Form 10-K BIOTRICITY INC. For: Mar 31 | SEC filing · Form 10-K | +0.00% | -14.44% | |
| Form NT 10-K BIOTRICITY INC. For: Mar 31 | SEC filing · Form NT | +0.00% | +10.63% | |
| Form 10-Q/A BIOTRICITY INC. For: Dec 31 | SEC filing · Form 10-Q | -3.23% | +3.87% | |
| Form 10-Q BIOTRICITY INC. For: Dec 31 | SEC filing · Form 10-Q | -1.32% | -5.16% | |
| Form NT 10-Q BIOTRICITY INC. For: Dec 31 | SEC filing · Form NT | +4.65% | +39.53% | |
| Form 10-Q BIOTRICITY INC. For: Sep 30 | SEC filing · Form 10-Q | +25.81% | +45.32% | |
| Form 10-Q BIOTRICITY INC. For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +15.52% | |
| Form NT 10-Q BIOTRICITY INC. For: Jun 30 | SEC filing · Form NT | +0.00% | -4.41% | |
| Form 10-K/A BIOTRICITY INC. For: Mar 31 | SEC filing · Form 10-K | -3.16% | -4.29% | |
| Form 10-K BIOTRICITY INC. For: Mar 31 | SEC filing · Form 10-K | -4.87% | -0.92% | |
| Form 10-Q BIOTRICITY INC. For: Dec 31 | SEC filing · Form 10-Q | +7.02% | +7.02% | |
| Form NT 10-Q BIOTRICITY INC. For: Dec 31 | SEC filing · Form NT | +0.00% | +1.14% | |
| Form 10-Q BIOTRICITY INC. For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +0.00% |
Keep exploring
More BTCY: analyst actions → · SEC filings → · BTCY overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Accelerate Diagnostics, Inc. (AXDX) | 125 | -0.16% | 36% |
| GENMAB A/S (GMXAY) | 125 | 0.00% | 38% |
| CLEMENTIA PHARMACEUTICALS INC COMMON SHARES (CMTA) | 124 | +0.03% | 51% |
| DAIICHI SANKYO S/ADR (DSNKY) | 124 | -0.03% | 46% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.